Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000315066-25-001679·CRESCENT BIOPHARMA, INC.
Schedule 13G ownership disclosure
CRESCENT BIOPHARMA INC.
COMMON STOCK · CUSIP: 38000Q201
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 1,414,190.00 · Class: 10.2%
- Abigail P. Johnson
Shares: 1,414,190.00 · Class: 10.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-001679
- Form type
- SCHEDULE 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Jul 08, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership